
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Barberry root bark (Berberis vulgaris) contains up to 4g/100g alkaloids, primarily berberine, which exerts anti-inflammatory effects by inhibiting COX-2 via AP-1 pathways and shifting Th1/Th2 immune balance. Berberine demonstrates antimicrobial activity and α-glucosidase inhibition, supporting traditional uses for digestive and metabolic health.

Reported Benefits (Provisional)
Origin & History

Barberry Root Bark, derived from Berberis vulgaris, is native to Europe, North Africa, and parts of Asia. This part of the plant is particularly rich in the alkaloid berberine, along with other beneficial compounds. It has been extensively used in traditional medicine for its potent therapeutic properties, primarily supporting liver, digestive, and immune health.
Research Narrative (Provisional)
Extensive pharmacological research, particularly on the alkaloid berberine found in barberry root bark, validates its efficacy in antimicrobial, antidiabetic, and anti-inflammatory applications. Clinical studies support its role in regulating blood sugar, improving lipid profiles, and supporting liver function.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Vitamin C - Phytochemicals: Berberine (alkaloid), Flavonoids (polyphenols), Tannins (polyphenols)
Reported Mechanism (Provisional)
Berberine, the primary bioactive alkaloid (up to 0.6 mg/mg extract), modulates inflammation by suppressing Th17 cells via ERK1/2-STAT3-RORγt pathways and Th1 cells through p38 MAPK/JNK-STAT1/STAT4 signaling. It inhibits pro-inflammatory cytokines (IL-1, TNF-α, IFN-γ) while stimulating anti-inflammatory IL-4/IL-10 production. Additional mechanisms include COX-2 inhibition via AP-1 suppression, α-glucosidase inhibition for glucose control, and antimicrobial activity through multiple pathways.
Clinical Narrative (Provisional)
Human clinical trials specific to barberry root bark are limited, with most evidence derived from in vitro studies and animal models. Available research focuses primarily on isolated berberine rather than whole root bark extracts. Some clinical trials have demonstrated berberine's efficacy for blood sugar regulation and lipid profiles, but quantified outcomes and sample sizes for barberry root bark specifically are not well-documented in current literature. The evidence base remains largely preclinical despite extensive traditional use.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







